Antioxidants help treat skin-picking disorder in mice, researcher says

July 13, 2015

Two antioxidant supplements are effective in treating skin-picking disorder in mice, according to a study led by a Stanford University School of Medicine researcher.

The finding suggests that people with the potentially serious disorder might benefit from this therapy.

An estimated 4 percent of the population—or about 1 in 25—suffer from skin-picking disorder, in which repeated, compulsive picking or scratching of the skin can lead to severe disfigurement and life-threatening infection. Skin picking is also common among laboratory mice, which may develop potentially fatal ulcerative dermatitis, or , caused by excessive grooming.

The condition is the single leading avoidable cause of death among , said Joseph Garner, PhD, associate professor of comparative medicine and senior author of the study, which was published online today in PLOS ONE. The lead author is Nneka George, DVM, of the University of North Carolina at Chapel Hill.

In the study, the researchers experimented with two —N-acetylcysteine and —to treat mice with skin-picking disorder. NAC is used by cells to make glutathione, which is the brain's main, naturally occurring antioxidant. NAC has been used experimentally in people with a variety of conditions, including Parkinson's disease, autism and cystic fibrosis, and reports of individual cases suggest it could be useful in treating skin picking.

Potentially fewer side effects from glutathione

"With NAC, almost every mouse got a little bit better," Garner said. "But there is a huge variability is response, anywhere from a slight improvement to complete cure, which is what you see in humans."

NAC also took a long time to show an effect: If an animal was cured, it took six to eight weeks. With glutathione, the pattern was very different. Fifty percent responded, but in these animals it was a rapid, all-or-nothing response: If they got better, they were completely cured in two to three weeks. The animals that didn't get better were worse off to start with, the researchers found.

Garner said the results suggest that glutathione might be an even more powerful therapeutic, with potentially fewer side effects.

"What's exciting is that we have a compound that works. It works as well as NAC. It's clearly working differently, or at least more directly. This different response profile gives us some hope that there may be some nonresponders, or people who can't tolerate NAC, who may be helped by glutathione," he said.

Skin-picking disorder is a surprisingly common condition, yet many patients avoid seeking help because of the shame and embarrassment, Garner said.

"This can lead to really serious disfigurement in extreme cases," he said. "People suffer in complete silence. They think they are the only one who has it, despite the fact that it's very common, and it kills people."

By the time people do seek help, about 35 percent have required some kind of antibiotic treatment, and 5 percent have required intravenous antibiotics to treat potentially life-threatening infections, he said. Some are referred for psychiatric help. Although cognitive behavioral therapy can be an effective form of treatment, there are few practitioners equipped to do this form of therapy, Garner said.

People with the condition also may be prone to compulsive hair pulling, another body-focused, repetitive-behavior disorder. A clinical trial among patients with the hair-pulling disorder, also known as trichotillomania, showed NAC to be an effective treatment in 56 percent of cases.

Study methods

In the latest study, the researchers selected 16 mice with lesions on the face, neck and limbs—signs of skin picking. Because the condition is painful and potentially fatal, the researchers treated all the mice with a thin film of topical antibiotic and steroidal ointment to relieve their discomfort. A third of the mice received a high dose of NAC in their drinking water. Another third were given drops of glutathione on the nose. (Because mice are nose breathers, they easily inhaled the compound.) A control group was given neither of the compounds.

Almost all the animals treated with NAC showed some improvement, though the improvement was slow. By the end of the study, 40 percent were fully cured. Among the animals treated with glutathione, results were more rapid: Within two to four weeks, about half were cured; the other half did not respond. There was no change among the control animals.

Garner believes that NAC works by combating oxidative stress that causes certain cells in the brain to die or become inactive.

"Our thought is maybe NAC works because in the brain it is the precursor to glutathione, and the brain has to make glutathione to protect itself against oxidative stress," he said.

NAC, however, isn't easily tolerated by many people, causing gastrointestinal distress, he said. Intra-nasal glutathione, on the other hand, may avoid these potential side effects by bypassing the gut and liver, delivering the compound directly to the brain. He first presented the results in April to a patient advocacy group.

"The sense of excitement from patients, advocates and researchers was palpable," he said. "This is the first new potential drug for this disorder in years."

Garner said his next step is to plan a clinical trial in patients to test the value of intra-nasal glutathione.

Explore further: Model could help counteract poisoning from popular painkiller

Related Stories

Model could help counteract poisoning from popular painkiller

June 22, 2015
New research could help reverse deadly side effects caused by excessive doses of the drug acetaminophen, the major ingredient in Tylenol and many other over-the-counter and prescription medicines.

Brain booster for bipolar disorder

May 19, 2014
(Medical Xpress)—Providing the brain with an energy boost could be a new way to treat bipolar depression.

NAC amino acid offers a potential therapeutic alternative in psychiatric disorders

October 7, 2013
Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is ...

Research shows oral supplement increases body's storage of antioxidant

April 23, 2013
(Medical Xpress)—Oral supplementation of glutathione is effective in increasing the body's stores of the antioxidant, said Penn State College of Medicine researchers in study results presented at a conference today (April ...

Recommended for you

Study reveals new mechanisms of cell death in neurodegenerative disorders

November 22, 2017
Researchers at King's College London have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

Researchers find infectious prions in Creutzfeldt-Jakob disease patient skin

November 22, 2017
Creutzfeldt-Jakob disease (CJD)—the human equivalent of mad cow disease—is caused by rogue, misfolded protein aggregates termed prions, which are infectious and cause fatal damages in the patient's brain. CJD patients ...

Surprising roles for muscle in tissue regeneration, study finds

November 22, 2017
A team of researchers at Whitehead has illuminated an important role for different subtypes of muscle cells in orchestrating the process of tissue regeneration. In a paper published in the November 22 issue of Nature, they ...

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.